Create Free Account

By creating account you will get access to hot stocks & personalised emails

Ramsay Health Care Ltd Pref

Healthcare AU RHCPA

106.5AUD
-0.11(0.10%)

Last update at 2024-05-14T05:49:00Z

Day Range

106.50107.00
LowHigh

52 Week Range

96.95107.20
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 527.10M 538.50M 741.60M 466.20M 846.83M
Minority interest -67.40000M -105.20000M 518.10M 483.40M 479.40M
Net income 298.10M 274.00M 449.00M 284.00M 545.47M
Selling general administrative 9431.00M 8309.50M 7817.60M 7571.80M 7171.24M
Selling and marketing expenses - - - - -
Gross profit 11515.30M 9974.30M 9339.60M 9128.10M 8624.58M
Reconciled depreciation 989.10M 927.60M 899.40M 893.20M 485.68M
Ebit 660.30M 460.90M 690.70M 689.00M 1051.10M
Ebitda 1777.40M 1612.90M 1804.90M 1544.80M 1500.81M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income 554.20M 230.60M 174.80M 860.80M 967.07M
Other operating expenses - - - - -
Interest expense 261.20M 146.80M 163.90M 185.40M 168.30M
Tax provision 181.50M 159.30M 230.10M 157.00M 274.44M
Interest income 39.90M 36.20M 7.10M 407.50M 156.22M
Net interest income -474.30000M -352.80000M -391.00000M -172.70000M -161.61500M
Extraordinary items - 8.10M 27.70M 2.60M -
Non recurring - - - - -
Other items - - - - -
Income tax expense 181.50M 159.30M 230.10M 157.00M 274.40M
Total revenue 14863.00M 13082.10M 12348.30M 12173.00M 11559.47M
Total operating expenses - - - - -
Cost of revenue 3347.70M 3107.80M 3008.70M 3044.90M 2934.89M
Total other income expense net 447.20M 660.70M 957.80M 447.80M 75.70M
Discontinued operations 19.90M 15.30M 15.30M 15.30M -
Net income from continuing ops 345.60M 379.20M 511.50M 309.20M 572.39M
Net income applicable to common shares 285.10M 265.00M 439.90M 272.70M 532.70M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 21030.20M 19473.30M 19324.60M 18058.70M 12639.80M
Intangible assets 407.30M 435.20M 467.30M 462.70M 496.30M
Earning assets - - - - -
Other current assets 279.30M 24.50M 1982.40M 39.20M 43.10M
Total liab 16207.00M 14947.10M 14773.80M 14306.20M 10096.10M
Total stockholder equity 4154.80M 3933.50M 4032.70M 3752.50M 2543.70M
Deferred long term liab - - - - -
Other current liab 180.30M 318.70M 562.80M 1230.70M 704.20M
Common stock 2216.40M 2197.60M 2197.60M 2197.60M 713.50M
Capital stock 2400.80M 2377.40M 2373.10M 2371.60M 883.67M
Retained earnings 1786.70M 1708.70M 1750.90M 1431.90M 1693.30M
Other liab 997.10M 939.60M 901.60M 908.90M 1341.60M
Good will 5756.40M 5363.80M 3766.30M 3783.40M 3767.00M
Other assets 719.00M 688.40M 622.00M 621.90M 544.20M
Cash 656.10M 314.20M 1004.80M 1503.70M 745.50M
Cash and equivalents - 314.20M 1004.80M 1503.70M 745.50M
Total current liabilities 3810.40M 3747.60M 3717.20M 3772.90M 2743.80M
Current deferred revenue - - - - -
Net debt 5275.30M 4902.10M 4275.90M 2724.10M 4497.99M
Short term debt - 0.00000M 0.00000M 0.00000M 0.00000M
Short long term debt 69.90M 42.80M 51.70M 32.30M 34.01M
Short long term debt total - - 10131.80M 9136.90M 5487.50M
Other stockholder equity -32.70000M -152.60000M -91.30000M -51.00000M -33.20000M
Property plant equipment 10187.20M 9436.00M 8900.10M 8925.10M 4642.80M
Total current assets 3895.80M 3285.50M 5351.40M 4060.80M 2919.20M
Long term investments 83.60M 338.90M 300.40M 328.40M 332.98M
Net tangible assets -2261.10000M -2139.50000M -453.10000M -745.80000M -1971.80000M
Short term investments - - - - -
Net receivables 2397.60M 2401.90M 1863.40M 1978.60M 1608.80M
Long term debt 5861.50M 5173.50M 5229.00M 4195.50M 5209.40M
Inventory 388.60M 376.80M 409.40M 411.00M 344.80M
Accounts payable 1484.30M 1483.50M 1164.60M 1148.60M 1035.30M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - -76.70000M -78.20000M -82.10000M
Accumulated amortization - - - - -
Non currrent assets other 10.60M 10.70M 10.90M 11.10M 11.27M
Deferred long term asset charges - - - - -
Non current assets total 17134.40M 16186.60M 13973.20M 13997.90M 9614.56M
Capital lease obligations 5954.90M 5482.40M 5271.00M 5289.20M 351.21M
Long term debt total - 10301.10M 10131.80M 9136.90M 5487.50M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -713.80000M -48.20000M -0.70000M -31.90000M -31.90000M
Change to liabilities 102.80M 124.70M 107.10M 890.50M 164.40M
Total cashflows from investing activities -713.80000M 30.00M -2504.20000M -656.00000M -1752.30000M
Net borrowings -3.60000M -1037.80000M 735.90M -1363.90000M 783.40M
Total cash from financing activities -242.40000M -1410.90000M 584.00M -231.90000M 812.00M
Change to operating activities -89.20000M -31.80000M 43.70M -51.60000M -15.00000M
Net income 298.10M 274.00M 449.00M 284.00M 545.50M
Change in cash 341.90M -690.60000M -498.90000M 758.20M -25.10000M
Begin period cash flow 314.20M 1004.80M 1503.70M 745.50M 770.57M
End period cash flow 656.10M 314.20M 1004.80M 1503.70M 745.45M
Total cash from operating activities 1279.60M 715.50M 1481.20M 1680.70M 903.30M
Issuance of capital stock - - - 1476.90M -
Depreciation 962.30M 906.90M 884.00M 875.10M 475.60M
Other cashflows from investing activities 19.90M 1972.20M -1916.60000M 47.30M 9.00M
Dividends paid 218.70M 351.90M 115.30M 322.50M 308.80M
Change to inventory -14.20000M 28.20M -11.40000M -84.00000M -19.60000M
Change to account receivables 118.20M -664.80000M -103.90000M -268.10000M -299.60000M
Sale purchase of stock - - 0.00000M 1467.10M -21.85000M
Other cashflows from financing activities -20.10000M -21.20000M -36.60000M -12.60000M 359.30M
Change to netincome -32.20000M 72.70M 67.60M 16.10M 6.00M
Capital expenditures 720.90M 708.50M 628.90M 680.60M 593.80M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - 4.20M 305.90M 235.20M -
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow 558.70M 7.00M 852.30M 1000.10M 309.50M

Fundamentals

  • Previous Close 106.61
  • Market Cap14305.48M
  • Volume2271
  • P/E Ratio65.12
  • Dividend Yield6.21%
  • EBITDA1407.50M
  • Revenue TTM15945.30M
  • Revenue Per Share TTM69.89
  • Gross Profit TTM 1646.80M
  • Diluted EPS TTM1.63

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
RHCPA
Ramsay Health Care Ltd Pref		 -0.11 0.10% 106.50 65.12 - 0.90 - - -
RHC
Ramsay Health Care Ltd		 0.51 1.00% 51.30 55.29 23.81 0.75 2.61 1.45 12.91
SNZ
Summerset Group Holdings Ltd		 0.14 1.54% 9.22 5.72 - 9.08 1.03 13.66 7.94
REG
Regis Healthcare Ltd		 0.06 1.49% 4.08 - 24.57 1.34 256.72 4.74 6.26
OCA
Oceania Healthcare Ltd		 -0.02 3.85% 0.50 26.00 - 1.63 0.43 4.00 22.56

Reports Covered

Stock Research & News

View All

Profile

Ramsay Health Care Limited owns and operates hospitals. The company offers health care services to public and private patients. It operates facilities in approximately 530 locations in the Asia Pacific, the United Kingdom, France, and Nordics. Ramsay Health Care Limited was founded in 1964 and is based in Sydney, Australia.

Ramsay Health Care Ltd Pref

126 Phillip Street, Sydney, NSW, Australia, 2000

Key Executives

Name Title Year Born
Mr. Craig Ralph McNally CEO, MD & Exec. Director 1961
Mr. Martyn J. Roberts Group Chief Financial Officer 1968
Ms. Kelly Hibbins Group Head of Investor Relations NA
Ms. Henrietta Rowe BECON, L.L.B. Group Gen. Counsel & Company Sec. NA
Ms. Colleen Harris Group Chief People Officer 1969
Mr. Andrew Wearne Global Chief Audit Exec. NA
Dr. Andrew Jones Group Chief Growth Officer 1974
Sir Edward Byrne AC, DSc, FMEDSCI, FRACP, FRCP, FTSE, M.D., MBA Group Chief Medical Officer 1952
Mr. Kah Peng Hong Group Chief Exec. Officer of Ramsay Sime Darby Health Care 1973
Doug Meagher CFO of Ramsay Australia NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Our Company

Useful Links

Contact Us

Market Research

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.